IRIS
SARACENO, ROSITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.368
AS - Asia 1.678
EU - Europa 1.662
Continente sconosciuto - Info sul continente non disponibili 244
SA - Sud America 237
AF - Africa 35
OC - Oceania 18
Totale 19.242
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.305
SG - Singapore 619
CN - Cina 529
IT - Italia 242
DE - Germania 229
RU - Federazione Russa 218
UA - Ucraina 213
BR - Brasile 181
FR - Francia 151
HK - Hong Kong 141
IE - Irlanda 135
SE - Svezia 123
GB - Regno Unito 106
VN - Vietnam 103
FI - Finlandia 76
PL - Polonia 62
IN - India 52
KR - Corea 52
BD - Bangladesh 44
JP - Giappone 37
CA - Canada 34
CO - Colombia 18
AR - Argentina 17
AU - Australia 17
ES - Italia 17
AE - Emirati Arabi Uniti 13
NL - Olanda 13
EG - Egitto 12
PH - Filippine 12
SK - Slovacchia (Repubblica Slovacca) 12
ZA - Sudafrica 10
CH - Svizzera 9
KG - Kirghizistan 9
MX - Messico 9
RO - Romania 9
TR - Turchia 9
GR - Grecia 8
IR - Iran 8
PY - Paraguay 8
BE - Belgio 7
AT - Austria 6
CR - Costa Rica 6
IQ - Iraq 6
MA - Marocco 6
PK - Pakistan 6
UZ - Uzbekistan 6
EC - Ecuador 5
LV - Lettonia 5
RS - Serbia 5
TW - Taiwan 5
CZ - Repubblica Ceca 4
LT - Lituania 4
MY - Malesia 4
NI - Nicaragua 4
PT - Portogallo 4
CL - Cile 3
EU - Europa 3
HN - Honduras 3
ID - Indonesia 3
JM - Giamaica 3
OM - Oman 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IL - Israele 2
PE - Perù 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SN - Senegal 2
TH - Thailandia 2
VE - Venezuela 2
BH - Bahrain 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
KY - Cayman, isole 1
LB - Libano 1
MM - Myanmar 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SV - El Salvador 1
UY - Uruguay 1
Totale 19.003
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.102
Houston 3.742
Wilmington 3.346
Fairfield 454
Singapore 390
Ann Arbor 348
Ashburn 333
Chandler 320
San Jose 224
Jacksonville 185
Beijing 167
Cambridge 166
Seattle 161
New York 138
Dublin 135
Hong Kong 135
Medford 110
Zhengzhou 92
Dearborn 90
Council Bluffs 76
Rome 75
Dallas 72
Los Angeles 68
The Dalles 66
Santa Clara 56
Lawrence 50
Bar Harbor 36
Kraków 35
Shanghai 34
Ho Chi Minh City 33
Moscow 33
Tokyo 32
Boardman 31
Lauterbourg 31
Buffalo 26
Helsinki 25
Menlo Park 25
Hanoi 24
San Diego 21
São Paulo 20
Orem 18
Redondo Beach 18
London 17
Munich 17
Mülheim 17
San Francisco 17
Hefei 16
Norwalk 16
Warsaw 16
Hangzhou 15
Nanjing 14
Detroit 13
Milan 13
Redwood City 13
Brooklyn 11
Chennai 11
Denver 11
Dubai 11
Guangzhou 11
Montreal 11
Toronto 10
Da Nang 9
Kunming 9
Phoenix 9
Stockholm 9
Atlanta 8
Chicago 8
Manchester 8
Paris 8
Boston 7
Columbus 7
Florence 7
Frankfurt am Main 7
Haiphong 7
Madrid 7
Nanchang 7
Palo Alto 7
Redmond 7
San Mateo 7
Verona 7
Brussels 6
Draper 6
Johannesburg 6
Poznan 6
Salt Lake City 6
Asunción 5
Bern 5
Bolzano 5
Dhaka 5
Fuzhou 5
Melbourne 5
Mountain View 5
Nuremberg 5
Philadelphia 5
Quezon City 5
Riga 5
San José 5
Trento 5
Turku 5
University Park 5
Totale 16.053
Salva come PNG Salva come JPEG
Nome #
Crusted scabies in a liver transplant patient mimicking rupioid psoriasis 1.398
Efficacy and safety of infliximab in psoriatic patients over the age of 65 557
Atopic dermatitis and dental manifestations 549
Topical lactoferrin can improve stable psoriatic plaque 514
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers 494
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis 493
Apremilast for the treatment of psoriasis. 483
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 482
Oral lichen planus: therapy and phenotype 478
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 464
New topical treatments for psoriasis 463
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review 462
Profile of certolizumab and its potential in the treatment of psoriatic arthritis 461
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 458
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 454
Role of IL-23 in the pathogenesis of psoriasis: A novel potential therapeutic target? 450
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 444
The significance of the development of antinuclear antibodies during infliximab treatment 436
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment 430
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 427
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 421
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 417
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 410
Erysipeloid cutaneous metastasis from bladder carcinoma 408
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 406
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 401
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 397
Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome 395
Prevalence and management of panic attacks during infliximab infusion in psoriatic patients 384
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 374
Serum Protein Profile Changes in Psoriatic Patients Undergoing Treatment With Infliximab 372
Does metabolic syndrome influence psoriasis? 366
The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: a retrospective long-term study 365
Tofacitinib for the treatment of moderate-to-severe psoriasis 364
Why 3 mg/kg instead of 5 mg/kg of infliximab should work in psoriatic arthritis? 333
Safety evaluation of apremilast for the treatment of psoriasis 327
Comparison of a novel treatment protocol with oral fluconazole vs probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 in the treatment of recurrent vulvovaginal candidiasis 309
A European perspective on the challenges of managing psoriasis 227
Oral lichen planus: Therapy and phenotype 217
308 nm monochromatic excimer light in the treatment of psoriasis 208
Different applications of monochromatic excimer light in skin diseases 194
Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides 179
Treatment of folliculitis with monochromatic excimer light (308 nm). 174
Aphthous, coeliac disease and other dental disorders in childhood 164
Randomized, within-patient, clinical trial comparing fluorine-synthetic fiber socks with standard cotton socks in improving plantar pustulosis 160
Type III juvenile pityriasis rubra pilaris: A successful treatment with infliximab [12] 159
Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab. 154
Nanomedicine in dermatology: Benefits and emerging applications 147
Clinical severity instruments 129
Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: A report of two cases 125
Keratosis punctata palmoplantaris and malignancies: case report 90
Apheresis in the treatment of recalcitrant atopic dermatitis: Case series and review of the literature 69
Totale 19.242
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.088
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022442 0 0 41 34 14 54 23 21 40 56 28 131
2022/2023815 70 63 37 119 87 153 56 48 98 11 39 34
2023/2024345 34 8 37 18 26 104 21 13 2 7 10 65
2024/2025980 47 193 106 77 34 58 102 36 74 96 98 59
2025/20261.918 166 95 239 184 196 67 261 196 205 149 92 68
2026/2027491 113 200 178 0 0 0 0 0 0 0 0 0
Totale 19.242